中国学者近期发表的论文 |
---|
1. | Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.
Author: Rao G, Wang H, Li B, Huang L, Xue D, Wang X, Jin H, Wang J, Zhu Y, Lu Y, Du L, Chen Q. Journal: Clin Cancer Res. 2013 Feb 15;19(4):785-97. doi: 10.1158/1078-0432.CCR-12-2788. Epub 2012 Dec 18. | 2. | The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.
Author: Li D, Wei P, Peng Z, Huang C, Tang H, Jia Z, Cui J, Le X, Huang S, Xie K. Journal: Clin Cancer Res. 2013 Jan 1;19(1):62-72. doi: 10.1158/1078-0432.CCR-12-1588. Epub 2012 Nov 7. | 3. | A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity.
Author: Tysome JR, Li X, Wang S, Wang P, Gao D, Du P, Chen D, Gangeswaran R, Chard LS, Yuan M, Alusi G, Lemoine NR, Wang Y. Journal: Clin Cancer Res. 2012 Dec 15;18(24):6679-89. doi: 10.1158/1078-0432.CCR-12-0979. Epub 2012 Oct 22. | 4. | Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Author: Zhang J, Zhang L, Su X, Li M, Xie L, Malchers F, Fan S, Yin X, Xu Y, Liu K, Dong Z, Zhu G, Qian Z, Tang L, Zhan P, Ji Q, Kilgour E, Smith PD, Brooks AN, Thomas RK, Gavine PR. Journal: Clin Cancer Res. 2012 Dec 15;18(24):6658-67. doi: 10.1158/1078-0432.CCR-12-2694. Epub 2012 Oct 18. | 5. | IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives.
Author: Yang H, Ye D, Guan KL, Xiong Y. Journal: Clin Cancer Res. 2012 Oct 15;18(20):5562-71. doi: 10.1158/1078-0432.CCR-12-1773. | 6. | FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
Author: Zhang N, Wu X, Yang L, Xiao F, Zhang H, Zhou A, Huang Z, Huang S. Journal: Clin Cancer Res. 2012 Nov 1;18(21):5961-71. doi: 10.1158/1078-0432.CCR-12-0039. Epub 2012 Sep 12. | 7. | The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Author: Zhuo W, Jia L, Song N, Lu XA, Ding Y, Wang X, Song X, Fu Y, Luo Y. Journal: Clin Cancer Res. 2012 Oct 1;18(19):5387-98. doi: 10.1158/1078-0432.CCR-12-0708. Epub 2012 Aug 29. | 8. | Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Author: Liu LP, Ho RL, Chen GG, Lai PB. Journal: Clin Cancer Res. 2012 Oct 15;18(20):5662-71. doi: 10.1158/1078-0432.CCR-12-0552. Epub 2012 Aug 28. | 9. | Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.
Author: Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G, Liu J, Pantel K. Journal: Clin Cancer Res. 2012 Oct 15;18(20):5701-10. doi: 10.1158/1078-0432.CCR-12-1587. Epub 2012 Aug 20. | 10. | Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.
Author: Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, Manuel ER, Diamond DJ, Raubitschek A, Badie B. Journal: Clin Cancer Res. 2012 Oct 15;18(20):5628-38. doi: 10.1158/1078-0432.CCR-12-1911. Epub 2012 Aug 17. |
|